POST LEONARD E

CIK 00012358625 companiesDALLAS, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001235862

Recent Transactions

50 trades

Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2026-06-24−5,000→ 106,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2026-06-24$70.00/sh−5,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2026-06-24$0.60/sh+5,000→ 5,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2026-06-22$0.60/sh+5,000→ 5,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2026-06-22−5,000→ 111,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2026-06-22$65.00/sh−5,000→ 0 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2026-06-11$27.06/sh−1,993→ 35,494 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2026-06-10+13,980→ 13,980 total
Award
uniQure N.V.$QURE
Ordinary Shares
2026-06-10+7,550→ 37,487 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2026-06-04$54.50/sh−1,000→ 0 total
Award
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2026-06-04+9,354→ 9,354 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2026-06-04−1,000→ 116,077 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2026-06-04$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-11-17−1,000→ 117,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-11-17$41.43/sh−1,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-11-17$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-10-13$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-10-13−1,000→ 118,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-10-13$43.25/sh−1,000→ 0 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-09-30$40.09/sh−5,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-09-30$0.60/sh+5,000→ 5,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-09-30−5,000→ 119,077 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-09-15−1,000→ 124,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-09-15$35.10/sh−1,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-09-15$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-09-03−1,000→ 125,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-09-03$28.00/sh−1,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-09-03$0.60/sh+1,000→ 1,000 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-07-17$28.00/sh−2,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-07-17−2,000→ 126,077 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-07-17$0.60/sh+2,000→ 2,000 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2025-06-20$14.45/sh−2,112→ 29,937 total
Award
uniQure N.V.$QURE
Ordinary Shares
2025-06-11+7,970→ 32,049 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2025-06-11+15,630→ 15,630 total
Award
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-06-05+24,165→ 24,165 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-05-21$28.00/sh−1,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-05-21−1,000→ 128,077 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-05-21$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-04-28$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-04-28−1,000→ 129,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-04-28$30.76/sh−1,000→ 0 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-03-17$28.00/sh−1,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-03-17$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-03-17−1,000→ 130,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-02-18$28.61/sh−1,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-02-18−1,000→ 131,077 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-02-18$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-01-13$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-01-13−1,000→ 132,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-01-13$29.66/sh−1,000→ 0 total

Companies

Recent Filings

Address

C/O CG ONCOLOGY, INC. 3000 PEGASUS PARK DRIVE, SUITE 1640

DALLAS, TX, 75247

View on SEC.gov